Skip to Content

Centene Corp

CNC: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$19.00LnphsRdytlstd

Centene Delivers Strong Q3 and Gives Solid Intermediate-Term Profit Goals; No FVE Change

Narrow-moat Centene turned in solid third-quarter results, including strong performance in its key end markets—Medicaid (low-income Americans) and Medicare Advantage (older Americans)—which allowed management to slightly increase the bottom end of its 2022 EPS outlook. Also, on the call, management gave a preview of its 2023 and 2024 profit goals, which are roughly in line with our estimates. Considering that solid outlook, we are maintaining our $95 fair value estimate.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CNC so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center